SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Wockhardt
Wockhardt
BSE: 532300|NSE: WOCKPHARMA|ISIN: INE049B01025|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 23, 17:00
750.90
5.15 (0.69%)
VOLUME 40,206
LIVE
NSE
Oct 23, 17:00
751.85
4.95 (0.66%)
VOLUME 113,143
News on Wockhardt
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Wockhardt's Q2 results on November 03, 2014

10.38 am | 21 Oct 2014 |  Source: Moneycontrol.com

Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 03, 2014, to consider and approve the ...

Commodity price fall to benefit India; like Hero: HDFC Sec 

10.16 am | 08 Oct 2014 |  Source: CNBC-TV18

Dipen Sheth, Head-Institutional Research, HDFC Securities prefers betting on Hero than Maruti....

Wockhardt's director R. A. Shah resigns

2.47 pm | 01 Oct 2014 |  Source: Moneycontrol.com

Wockhardt Ltd has informed BSE that Mr. R. A. Shah, the Non Executive Independent Director of the Company has relinquished directorship of the Company...

USFDA bans two Indian plants on GMP violations

9.28 pm | 26 Sep 2014 |  Source: CNBC-TV18

The USFDA has served import alerts to Canadian drug company Apotex Research’s manufacturing facility in Bangalore and Indian firm Micro Labs manufac...

Go long in Wockhardt, says Rahul Mohindar 

2.57 pm | 23 Sep 2014 |  Source: CNBC-TV18

Rahul Mohindar of viratechindia.com recommends going long in Wockhardt with a target of Rs 920....

Here are Rahul Mohindar's top trading ideas 

1.48 pm | 23 Sep 2014 |  Source: CNBC-TV18

Watch the interview of Rahul Mohindar, Technical Analyst at viratechindia.com with Ekta Batra & Reema Tendulkar on CNBC-TV18, in which he shared his r...

Pharma sector could trend in second half: Kotak 

12.12 pm | 22 Sep 2014 |  Source: CNBC-TV18

Sandeep Bhatia, Executive Director & Head of Sales at Kotak Institutional Equities says one should continue to hold on to big pharma names....

Prefer pharma, Tata Steel, Ambuja Cements: Sanju Verma 

12.28 pm | 18 Sep 2014 |  Source: CNBC-TV18

Sanju Verma, CEO at Violet Arc Global Managers is of the view that one may prefer pharma stocks, Tata Steel from the metal space and Ambuja Cements fr...

Stocks in news: Aurobindo, Maruti, Bhushan, Apollo Tyres

8.26 am | 17 Sep 2014 |  Source: CNBC-TV18

Allahabad Bank | IDFC | Wockhardt | Aurobindo Pharma | NTPC | Maruti Suzuki | Financial Technologies | Axis Bank | Bhushan Steel | Gail India | Jet Ai...

Wockhardt: Outcome of board meeting

5.51 pm | 16 Sep 2014 |  Source: Moneycontrol.com

Wockhardt has informed that the Board of Directors of the Company at its meeting held on September 15, 2014, approved a scheme of Amalgamation for am...

Here are top 10 stocks to keep an eye on Sep 16 

8.56 am | 16 Sep 2014 |  Source: CNBC-TV18

Here are top 10 stocks to keep an eye on Sep 16 - Hero Motocorp, Eicher, Unitech, Infosys, Yes Bank, ZF Steering, Wockhardt, GMR Infra, Tata Motors an...

Stocks in news: BPCL, Bajaj Electricals, Fortis, KS Oils

8.20 am | 15 Sep 2014 |  Source: CNBC-TV18

SAIL | BPCL | HPCL | IOC | YES Bank | JSW Steel | Bajaj Electricals | PTC India Financial | Fortis Healthcare | Wockhardt | KS Oils and United Breweri...

Buy Wockhardt; target of Rs 740: Way2Wealth

1.00 pm | 14 Aug 2014 |  Source: Moneycontrol.com

Way2Wealth is bullish on Wockhardt and has recommended buy rating on the stock with a target of Rs 740 in its July 22, 2014 research report....

Wockhardt consolidated Jun '14 sales at Rs 991.19 crore

11.39 am | 13 Aug 2014 |  Source: Moneycontrol.com

Wockhardt has reported a consolidated total income from operations of Rs 991.19 crore and a net profit of Rs 19.95 crore for the quarter ended Jun '14...

Drugmaker Wockhardt Q1 net profit plunges 94% on plant bans

1.01 pm | 12 Aug 2014 |  Source: Reuters

The United States is Wockhardt's biggest market and the FDA has banned the import of generic drugs from two of the company's plants in India, citing q...

Wockhardt Q4 profit slips 77% to Rs 75.7 cr, OPM drops 25%

5.46 pm | 26 May 2014 |  Source: Moneycontrol.com

Drug maker Wockhardt's consolidated profit after tax dropped 77 percent year-on-year to Rs 75.7 crore in the quarter ended March 2014, driven by lower...

1 2 3
Quick Links for Wockhardt
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.